363. DIFFERENTIAL EFFECTS OF PSILOCYBIN AND LISURIDE ON SEROTONIN AND DOPAMINE NEURONAL ACTIVITY AND BEHAVIOR
B. D. Richardson(Southern Illinois University School of Medicine), Gabriella Gobbi(McGill University), Nahum Sonenberg(McGill University), Danilo De Gregorio(University of Campania "Luigi Vanvitelli"), Valeria Bruno(Istituto Neurologico Mediterraneo), Thomas Prudhomme(Société Francophone du Diabète), Marco Leyton(Montreal Neurological Institute and Hospital), Marco Pileggi(Hudson Institute), Sofia Nasini(University of Padua), Francis Rodriguez Bambico(Université de Montréal), Derek Wan-Yan-Chan(Memorial University of Newfoundland), Jeffrey Sprouse(Stornoway Diamond (Canada)), Ilia Shareghi-Ghahreman(McGill University), Tor A. Strand(Innlandet Hospital Trust)
Cited by 0
Related Papers
Upstream and downstream of mTOR
|Genes & Development|2004|4.2k
Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis
|Clinical Gastroenterology and Hepatology|2018|1.7k
Regulation of translation initiation by FRAP/mTOR
|Genes & Development|2001|1.5k
Translational control in stress and apoptosis
|Nature Reviews Molecular Cell Biology|2005|1.4k
Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism
|Genes & Development|1999|1.3k